Emerald Mutual Fund Advisers Trust raised its position in shares of Ultragenyx Pharmaceutical Inc. ( NASDAQ:RARE – Get Rating ) by 6.1% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 252,852 shares of the biopharmaceutical company's stock after purchasing an additional 14,648 shares during the period. Emerald Mutual Fund Advisers Trust's holdings in Ultragenyx Pharmaceutical were worth $11,715,000 as of its most recent filing with the Securities & Exchange Commission.

https://www.dailypolitical.com/2023/04/22/emerald-mutual-fund-advisers-trust-purchases-14648-shares-of-ultragenyx-pharmaceutical-inc-nasdaqrare.html

#dailypolitical